Cargando…

Is melatonin deficiency a unifying pathomechanism of high risk patients with COVID-19?

Detalles Bibliográficos
Autores principales:	Simko, Fedor, Reiter, Russel J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832439/ https://www.ncbi.nlm.nih.gov/pubmed/32504754 http://dx.doi.org/10.1016/j.lfs.2020.117902

Ejemplares similares

Melatonin as a rational alternative in the conservative treatment of resistant hypertension
por: Simko, Fedor, et al.
Publicado: (2019)

Melatonin as a Potential Approach to Anxiety Treatment
por: Repova, Kristina, et al.
Publicado: (2022)

Melatonin, coronavirus, cardiovascular disease, and the geriatric emergency: let's use everything we have!
por: Domínguez-Rodríguez, Alberto, et al.
Publicado: (2020)

Fluvoxamine, melatonin and COVID-19
por: Anderson, George M.
Publicado: (2021)

Lactacystin-induced kidney fibrosis: Protection by melatonin and captopril
por: Repova, Kristina, et al.
Publicado: (2022)

Delirium, sleep, COVID-19 and melatonin
por: Wiwanitkit, Viroj
Publicado: (2020)

Therapeutic Algorithm for Use of Melatonin in Patients With COVID-19
por: Reiter, Russel J., et al.
Publicado: (2020)

Effect of Melatonin on the Renin-Angiotensin-Aldosterone System in l-NAME-Induced Hypertension
por: Simko, Fedor, et al.
Publicado: (2018)

Melatonin and cancer suppression: insights into its effects on DNA methylation
por: Davoodvandi, Amirhossein, et al.
Publicado: (2022)

Rapid effect of suvorexant and high-dose melatonin on COVID-19 associated delirium
por: Nazeer, Sahana, et al.
Publicado: (2023)

Mechanisms and clinical evidence to support melatonin's use in severe COVID-19 patients to lower mortality
por: Tan, Dun-Xian, et al.
Publicado: (2022)

Toward a unified pathophysiology in COVID-19 acute aortopathies
por: Roncati, Luca, et al.
Publicado: (2021)

Melatonin: Regulation of Viral Phase Separation and Epitranscriptomics in Post-Acute Sequelae of COVID-19
por: Loh, Doris, et al.
Publicado: (2022)

Melatonin-Deficient Balb/c Mice and Their Use in Cancer Research
por: Kennaway, David J.
Publicado: (2019)

Chronotherapy of cardiovascular pathologies: a hopeful strategy
por: Simko, Fedor, et al.
Publicado: (2022)

Elderly as a High-risk Group during COVID-19 Pandemic: Effect of Circadian Misalignment, Sleep Dysregulation and Melatonin Administration
por: Cardinali, Daniel P., et al.
Publicado: (2020)

Increased risk for Covid-19 in patients with Vitamin D deficiency
por: Katz, Joseph
Publicado: (2021)

Melatonin as fetal neuroprotection: Links and risks
por: Ghotbizadeh Vahdani, Fahimeh, et al.
Publicado: (2020)

Clinical Trials for Use of Melatonin to Fight against COVID-19 Are Urgently Needed
por: Kleszczyński, Konrad, et al.
Publicado: (2020)

Heme oxygenase agonists—fluvoxamine, melatonin—are efficacious therapy for Covid-19
por: Hooper, Philip L.
Publicado: (2021)

Early Treatment of Acute Myocardial Infarction with Melatonin: Effects on MMP-9 and Adverse Cardiac Events
por: Domínguez-Rodríguez, Alberto, et al.
Publicado: (2022)

COVID-19: Melatonin as a potential adjuvant treatment
por: Zhang, Rui, et al.
Publicado: (2020)

Melatonin: highlighting its use as a potential treatment for SARS-CoV-2 infection
por: Reiter, Russel J., et al.
Publicado: (2022)

Melatonin: Regulation of Biomolecular Condensates in Neurodegenerative Disorders
por: Loh, Doris, et al.
Publicado: (2021)

The Multiple Functions of Melatonin: Applications in the Military Setting
por: Gancitano, Giuseppe, et al.
Publicado: (2022)

Peripheral and Central Effects of Melatonin on Blood Pressure Regulation
por: Pechanova, Olga, et al.
Publicado: (2014)

Biological consequences of zinc deficiency in the pathomechanisms of selected diseases
por: Jurowski, Kamil, et al.
Publicado: (2014)

Melatonin: Revisited Role as Vaccine Adjuvant During Outbreaks of COVID-19 Caused by the Delta Variant
por: Kow, Chia Siang, et al.
Publicado: (2021)

Coronavirus Disease 2019 (COVID-19) and Its Neuroinvasive Capacity: Is It Time for Melatonin?
por: Romero, Alejandro, et al.
Publicado: (2020)

Light, Water, and Melatonin: The Synergistic Regulation of Phase Separation in Dementia
por: Loh, Doris, et al.
Publicado: (2023)

Clinical Uses of Melatonin in Pediatrics
por: Sánchez-Barceló, Emilio J., et al.
Publicado: (2011)

Melatonin effect on platelets and coagulation: Implications for a prophylactic indication in COVID-19
por: Hosseinzadeh, Azam, et al.
Publicado: (2022)

Author reply to letter to editor “melatonin as fetal neuroprotection: Links and risks”
por: Lien, Reyin
Publicado: (2020)

New proposal involving nanoformulated melatonin targeted to the mitochondria as a potential COVID-19 treatment
por: Martín Giménez, Virna Margarita, et al.
Publicado: (2020)

Melatonin reduces lipid peroxidation and membrane viscosity
por: Reiter, Russel J., et al.
Publicado: (2014)

Melatonin: Regulation of Prion Protein Phase Separation in Cancer Multidrug Resistance
por: Loh, Doris, et al.
Publicado: (2022)

Erratum to: Biological consequences of zinc deficiency in the pathomechanisms of selected diseases
por: Jurowski, Kamil, et al.
Publicado: (2015)

Psychosis: glia, immunity, and melatonin
por: Anderson, George
Publicado: (2017)

Melatonin’s actions are not limited to sleep
por: Venaki, Evangelia, et al.
Publicado: (2023)

COVID-19 patients could be at high risk for dry socket
por: Shetty, Lakshmi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o1iadi0aeet6aculnujc1da6qc